BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20410082)

  • 1. Glutamine prevents fibrosis development in rats with colitis induced by 2,4,6-trinitrobenzene sulfonic acid.
    San-Miguel B; Crespo I; Kretzmann NA; Mauriz JL; Marroni N; Tuñón MJ; González-Gallego J
    J Nutr; 2010 Jun; 140(6):1065-71. PubMed ID: 20410082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis.
    Kretzmann NA; Fillmann H; Mauriz JL; Marroni CA; Marroni N; González-Gallego J; Tuñón MJ
    Inflamm Bowel Dis; 2008 Nov; 14(11):1504-13. PubMed ID: 18623154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid.
    Latella G; Sferra R; Vetuschi A; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Gaudio E
    Eur J Clin Invest; 2008 Jun; 38(6):410-20. PubMed ID: 18489401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model.
    Zhu MY; Lu YM; Ou YX; Zhang HZ; Chen WX
    J Dig Dis; 2012 Aug; 13(8):421-9. PubMed ID: 22788928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daikenchuto, a Kampo medicine, regulates intestinal fibrosis associated with decreasing expression of heat shock protein 47 and collagen content in a rat colitis model.
    Inoue K; Naito Y; Takagi T; Hayashi N; Hirai Y; Mizushima K; Horie R; Fukumoto K; Yamada S; Harusato A; Hirata I; Omatsu T; Yoshida N; Uchiyama K; Ishikawa T; Handa O; Konishi H; Wakabayashi N; Yagi N; Ichikawa H; Kokura S; Yoshikawa T
    Biol Pharm Bull; 2011; 34(11):1659-65. PubMed ID: 22040876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis.
    Crespo I; San-Miguel B; Prause C; Marroni N; Cuevas MJ; González-Gallego J; Tuñón MJ
    PLoS One; 2012; 7(11):e50407. PubMed ID: 23209735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept attenuates TNBS-induced experimental colitis: role of TNF-α expression.
    Paiotti AP; Miszputen SJ; Oshima CT; Artigiani Neto R; Ribeiro DA; Franco M
    J Mol Histol; 2011 Oct; 42(5):443-50. PubMed ID: 21863329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling.
    Loeuillard E; Bertrand J; Herranen A; Melchior C; Guérin C; Coëffier M; Aziz M; Déchelotte P; Savoye G; Marion-Letellier R
    World J Gastroenterol; 2014 Dec; 20(48):18207-15. PubMed ID: 25561788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of excess collagen IαI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice.
    Mahavadi S; Flynn RS; Grider JR; Qiao LY; Murthy KS; Hazelgrove KB; Kuemmerle JF
    Inflamm Bowel Dis; 2011 Mar; 17(3):711-9. PubMed ID: 20722057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B.
    Lawrance IC; Wu F; Leite AZ; Willis J; West GA; Fiocchi C; Chakravarti S
    Gastroenterology; 2003 Dec; 125(6):1750-61. PubMed ID: 14724828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production.
    Carvalho AT; Souza H; Carneiro AJ; Castelo-Branco M; Madi K; Schanaider A; Silv F; Pereira Junior FA; Pereira MG; Tortori C; Dines I; Carvalho J; Rocha E; Elia C
    World J Gastroenterol; 2007 Apr; 13(15):2166-73. PubMed ID: 17465495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-alpha, NF-kappaBp65, IL-6) in TNBS-induced colitis in rats.
    Zhou YH; Yu JP; Liu YF; Teng XJ; Ming M; Lv P; An P; Liu SQ; Yu HG
    Mediators Inflamm; 2006; 2006(5):92642. PubMed ID: 17392580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of proprotein convertase subtilisin/kexin type 9 attenuates 2,4,6-trinitrobenzenesulfonic acid-induced colitis via repressing toll-like receptor 4/nuclear factor-kappa B.
    Lei L; Li X; Yuan YJ; Chen ZL; He JH; Wu JH; Cai XS
    Kaohsiung J Med Sci; 2020 Sep; 36(9):705-711. PubMed ID: 32396274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J; Zheng C; Huang Y; Liang Y
    Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nilotinib-mediated mucosal healing in a rat model of colitis.
    Ataca P; Soyturk M; Karaman M; Unlu M; Sagol O; Dervis Hakim G; Yilmaz O
    World J Gastroenterol; 2013 Oct; 19(37):6237-44. PubMed ID: 24115822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin expression in colon during trinitrobenzene sulfonic acid-induced colitis in rats.
    Gotardo ÉM; Ribeiro Gde A; Clemente TR; Moscato CH; Tomé RB; Rocha T; Pedrazzoli J; Ribeiro ML; Gambero A
    World J Gastroenterol; 2014 Apr; 20(15):4345-52. PubMed ID: 24764672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
    World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.
    Latella G; Vetuschi A; Sferra R; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Flanders KC; Gaudio E
    Eur J Clin Invest; 2009 Feb; 39(2):145-56. PubMed ID: 19200168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats.
    Paiotti AP; Ribeiro DA; Silva RM; Marchi P; Oshima CT; Neto RA; Miszputen SJ; Franco M
    J Mol Histol; 2012 Jun; 43(3):307-17. PubMed ID: 22426941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical examination of anti-inflammatory and anti-apoptotic effects of hesperetin on trinitrobenzene sulfonic acid induced colitis in rats.
    Polat FR; Karaboğa I
    Biotech Histochem; 2019 Apr; 94(3):151-158. PubMed ID: 30383440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.